2024-10-10 09:00
GSK shares jump after landmark £1.68bn heartburn drug settlement
The pharmaceutical giant has settled the vast majority of cases around its drug Zantac in the US, boosting investor confidence in the company.

https://www.standard.co.uk/news/uk/gsk-hargreaves-lansdown-connecticut-pfizer-b1186984.html

#thisislondon